A.A. Fadda et al. / European Journal of Medicinal Chemistry 44 (2009) 1250–1256
1255
5.1.6. Ethyl-4-benzoyl-3-methyl-5-(phenylamino)thiophene-2-
carboxylate (15)
precipitated on hot then filtered off dried and recrystallized from
DMF:EtOH (1:1) to give compound 20c.
To a cold suspension of potassium hydroxide (0.56 g, 10 mmol)
in DMF (30 ml), benzoyl acetone was added (1.62 g, 10 mmol) and
followed by phenyl isothiocyanate (1.35 g, 10 mmol). The mixture
was stirred overnight at room temperature and treated with the
bromodiethyl malonate (2.39, 10 mmol), stirring was continued
for 4 h. The reaction mixture was poured onto ice-cold water.
Acidification using dilute HCl until the medium becomes acidic
gave solid product 15 which was filtered off, washed with water,
dried and recrystallized from aqueous ethanol to give compound
15.
Yellow crystal (Yield 35%), m.p. 210 ꢁC; IR (KBr):
n
/cmꢀ1 ¼3060
and 3100 for two (CH3), 1670 and 1660–1670 for three (C]O); 1H
NMR: (DMSO-d6), d 2.3 (s, 3H, CH3), 4.0 (s, 3H, CH3), 7.1–7.8 (m, 14H,
Ar), 10.24 (s, 1H, NH); MS: m/z (%) 456 (Mþ, 85); Anal. Calcd for
C26H20N2O4S (456): C, 68.41; H, 4.42; N, 5.26; Found: C, 68.40; H,
4.42; N, 5.00.
5.1.11. (3-Methyl-5-(phenylamino)-1H-pyrazol-4-
yl)(phenyl)methanone (22)
A mixture of equimolecular amounts of 3 (2.97 g, 10 mmol) and
hydrazine hydrate (0.32 g, 10 mmol) was refluxed in ethanol
(20 ml) and TEA (4 drops) for 2 h. The reaction mixture was poured
onto ice-cold water, filtered off and recrystallized from ethanol to
give the corresponding pyrazole 22.
Yellow crystal (Yield 70%), m.p. 162 ꢁC; IR (KBr):
n
/cmꢀ1 ¼3448
(NH), 1710 and 1670 for two (C]O); MS: m/z (%) 365 (Mþ, 100), 304
(20.54), 260 (10.69), 246 (12.32), 147 (11.70), 128 (6.79), 77 (31.43);
Anal. Calcd for C21H19NO3S (365): C, 69.02; H, 5.24; N, 3.83; Found:
C, 68.72; H, 4.94; N, 3.53.
Yellow crystal (Yield 76%), m.p. 160 ꢁC; IR (KBr):
n
/cmꢀ1 ¼3405
and 3286 (two NH), 1665 (C]O); MS: m/z (%) 277 (Mþ, 42); Anal.
Calcd for C17H15N3O (277): C, 73.63; H, 5.45; N, 15.16; Found: C,
73.33; H, 5.15; N, 14.86.
5.1.7. 1-4-Benzoyl-3-methyl-5-(phenylamino)thiophene-2-
ethanone (17)
To a cold suspension of potassium hydroxide (0.56 g, 10 mmol)
in DMF (30 ml), benzoyl acetone was added (1.62 g, 10 mmol) and
followed by phenyl isothiocyanate (1.35 g, 10 mmol). The mixture
was stirred overnight at room temperature and treated with the
chloroacetone (0.925, 10 mmol), stirring was continued for 4 h. The
reaction mixture was poured onto ice-cold water. Acidification
using dilute HCl until the medium becomes acidic gave solid
product 17 which was filtered off, washed with water, dried and
recrystallized from aqueous ethanol to give compound 17.
5.2. Molluscicidal activity tests
The molluscicidal activity tests were carried out by determina-
tion of the half lethal dose LC50 and sublethal dose LC90 of each
compound under investigation. B. alexandrina snails were collected
from the field (water canals) and maintained under laboratory
conditions for a period of 45 days before the tested and fed daily
with lettuce leaves. Then, the snails were examined to ensure that
they were free from parasitic infection. A series of concentrations
(seven) ranging from 4 to 16 ppm of each compound under
investigation were prepared. The required amount of the
compound under investigation was mixed thoroughly with few
drops of Tween 20 followed by addition of the appropriate volume
of untreated raw water (taken directly from the River Nile) to get
a homogeneous suspension with the necessary concentration, it
was poured in glass jar vessels 15 ꢃ 25 ꢃ 20 cm dimensions fitted
with air bubblers. Ten snails having the same size and diameter (ca.
7 mm) were used in each experiment and maintained in the tested
solution under laboratory conditions at ambient temperature for
24 h. Each experiment was repeated three times and the mean
number of killed snails was taken for each concentration as shown
in Table 1. A control group was taken by placing 10 snails in water
containing few drops of Tween 20. These bioassays are in accor-
dance with the W.H.O. guidelines [24].
Yellow crystal (Yield 59%), m.p. 230 ꢁC; IR (KBr):
n
/cmꢀ1 ¼3444
(NH), 1710 and 1665 for two (C]O); 1H NMR: (DMSO-d6),
d 2.2 (s,
3H, CH3), 2.5 (s, 3H, CH3), 7.1–7.7 (m, 10H, Ar), 10.24 (s, 1H, NH); MS:
m/z (%) 335 (Mþ, 22), 304 (20.54), 260 (10.69), 246 (12.32), 147(21);
Anal. Calcd for C20H17NO2S (335): C, 71.62; H, 5.11; N, 4.17; Found:
C, 71.321; H, 4.81; N, 3.77.
5.1.8. (Z)-1-Phenyl-2-(3-phenyl-1,3,4-thiadiazol-2-(3H)-
ylidene)butane-1,3-dione (20a)
A mixture of 3 (2.97 g, 10 mmol) and phenylazophenacyl
bromide (3.03 g, 10 mmol) in the presence of boiling ethanol
(20 ml) and TEA (4 drops) was heated for 2 h. The solid product that
separated while hot was precipitated on hot then filtered off, dried
and recrystallized from DMF:EtOH (1:1) to give compound 20a.
Yellow crystal (Yield 87%), m.p. 188 ꢁC; IR (KBr):
n
/cmꢀ1 ¼3060
(CH3), 1670 and 1665–1660 for three (C]O); MS: m/z (%) 426 (Mþ,
12); Anal. Calcd for C25H18N2O3S (426): C, 70.40; H, 4.25; N, 5.63;
Found: C, 70.40; H, 4.00; N, 5.33.
Acknowledgments
5.1.9. (Z)-2-(3-(p-Tolyl)-1,3,4-thiadiazol-2-(3H)-ylidene)-1-
phenyl-butane-1,3-dione (20b)
The authors are grateful to Agricultural Research Center for
biological evaluation, Mansoura, Egypt.
A mixture of 3 (2.97 g, 10 mmol) and p-tolylazo phenacyl
bromide (3.17 g, 10 mmol) in the presence of boiling ethanol and
TEA (4 drops) was heated for 2 h. The reaction mixture precipitated
on hot then filtered off dried and recrystallized from DMF:EtOH
(1:1) to give compound 20b.
References
[1] F.S. Mecullough, P. Gayral, J. Duncan, J.D. Christie, Bull. World Health Organ. 58
(1980) 681–689.
[2] J.A. Duncan, in: T.C. Cheng (Ed.), Molluscicides in Schistosomiasis Control,
Academic Press, New York, 1974, pp. 9–40.
[3] R. Gonnet, Bull. World Health Organ. 25 (1961) 483–501.
[4] L.S. Ritchie, I. Fox, Bull. World Health Organ. 39 (1968) 312–315.
[5] G.A. Nawwar, F.M. Abdelrazek, R.H. Swellam, Arch. Pharm. (Weinheim) 324
(1991) 875–877.
[6] G. Madulo-Leblond, P. Gayral, J.M. Clavel, R. Royer, Eur. J. Med. Chem. 16 (1981)
267–270.
[7] P. Gayral, J.P. Buisson, R. Royer, Eur. J. Med. Chem. 20 (1985) 187–189.
[8] F.M. Abdelrazek, P. Metz, E.K. Farrag, Arch. Pharm. Med. Chem. 337 (2004)
482–485.
[9] F.M. Abdelrazek, P. Metz, N.H. Metwally, S.F. Mahrouky, Arch. Pharm. Chem.
Life Sci. 339 (2006) 456–460.
Yellow crystal (Yield 74%), m.p. 226 ꢁC; IR (KBr):
n
/cmꢀ1 ¼3060
and 3065 for two (CH3), 1675 and 1660–1670 for three (C]O); 1H
NMR: (DMSO-d6),
d 1.97 (s, 3H, CH3), 2.3 (s, 3H, CH3), 7.1–7.8 (m,
14H, Ar); MS: m/z (%) 440 (Mþ, 26). Anal. Calcd for C26H20N2O3S
(440): C, 70.89; H, 4.58; N, 6.36; Found: C, 70.88; H, 4.50; N, 3.00.
5.1.10. (Z)-2-(3-(4-Methoxyphenyl)-1,3,4-thiadiazol-2-(3H)-
ylidene)-1-phenylbutane-1,3-dione (20c)
A mixture of 3 (2.97 g, 10 mmol) and 4-methoxyphenylazo-
phenacyl bromide (3.33 g, 10 mmol) in the presence of boiling
ethanol and TEA (4 drops) was heated for 2 h. The reaction mixture
[10] A.A. Fadda, M.M. Girges, M.A. Hanna, Chem. Pap. 47 (3) (1993) 186.